United States · Growth startup

Who invested in Portola Pharmaceuticals

5 rounds we have observed, with the 22 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$249Mraised across 5 rounds since 2003, from 5 sources

$21MSeries A$70MSeries C$60MSeries C$89MSeries D$9.0MGrowth
Latest round
Growth, $9.0MDec 2011
Biggest round
$89MSeries D · Nov 2011
Investors
22
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2005200720092011
$21MSeries A$70MSeries C$60MSeries C$89MSeries D$9.0MGrowth
First round
Series A, $21M
Dec 2003
Biggest round
$89M
Series D · Nov 2011
Usual gap between rounds
2.4 years
the median of 3

The rounds

  1. Dec 2011
    Growth$9.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $89M sold, first sale Nov 2011

  2. Nov 2011
    Series D$89M2 new

    Reported by portola.comSEC filing: $89M sold, first sale Nov 2011

  3. Jun 2009
    Series C$60M7 new11 returning

    From a historical funding recordSEC filing: $60M sold, first sale Jul 2008

  4. May 2007
    Series C$70M8 new4 returning

    From a historical funding record

  5. Dec 2003
    Series A$21M5 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2003Series C2007Series C2009Series D2011Growth2011Sutter Hill VenturesMPM CapitalFrazier Healthcare PartnersAbingworthGoldman SachsAdvanced Technology VenturesAlta PartnersT. Rowe PriceProspect Venture PartnersBrookside Capital

The exit

ExitListingPriceWhen
IPONASDAQ:PTLA$100MMay 2013

From historical deal records. Wrong? Tell us.

Everyone who backed them

Sutter Hill VenturesVC firm3rounds
MPM CapitalPrivate equity3rounds
Frazier Healthcare PartnersPrivate equity3rounds
AbingworthVC firm3rounds
Goldman SachsPrivate equity2rounds
Advanced Technology VenturesVC firm2rounds
Alta PartnersVC firm2rounds
T. Rowe PricePrivate equity2rounds
Prospect Venture PartnersVC firm2rounds
Brookside CapitalHedge fund2rounds
AllianceBernsteinVC firm2rounds
Temasek HoldingsVC firm1round
Adage Capital ManagementAsset manager1round
D.E. Shaw & Co.Growth equity1round
Ontario Teachers' Pension PlanVC firm1round
Janus Capital GroupGrowth equity1round
Pac-LinkVC firm1round
Eastern CapitalVC firm1round
Apothecary CapitalVC firm1round
IBT Management CorporationVC firm1round
Prospect StreetGrowth equity1round
Teachers' Private CapitalGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Portola Pharmaceuticals

Who invested in Portola Pharmaceuticals?

Portola Pharmaceuticals's investors include Sutter Hill Ventures, MPM Capital, Frazier Healthcare Partners, Abingworth and Goldman Sachs, and 17 more on record.

How much has Portola Pharmaceuticals raised?

Portola Pharmaceuticals has raised $249M across 5 rounds since 2003.

When did Portola Pharmaceuticals last raise?

Portola Pharmaceuticals's most recent round was a Growth of $9.0M in Dec 2011.

What was Portola Pharmaceuticals's biggest round?

Portola Pharmaceuticals's largest round on record is $89M (Series D), in Nov 2011.

Who backed Portola Pharmaceuticals first?

Portola Pharmaceuticals's first round on record, in Dec 2003, was backed by Sutter Hill Ventures, MPM Capital and Frazier Healthcare Partners and 2 others.

What stage is Portola Pharmaceuticals at?

Portola Pharmaceuticals's latest named round is a Growth, in Dec 2011.

Where is Portola Pharmaceuticals based?

Portola Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app